
CDMO0.00%14.3%

CRL+73.11%14.3%

DGX+27.21%14.3%

FTRE+89.49%14.3%

LH+13.11%14.3%

MRVI+118.48%14.3%

NOTV0.00%14.3%
As of Oct 9, 2026, 4:27 AM ET
MedTech Long '24: Lab Research & Trials Constituents
Avid Bioservices, Inc.CDMO | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $361.4M |
Charles River Laboratories International, Inc.CRL | 14.3% | -0.77% | 1.16% | 7.06% | 3.89% | 49.39% | 66.96% | 99.62% | 73.11% | 59.50% | -27.17% | $14.35B |
Fortrea Holdings Inc.FTRE | 14.3% | -0.92% | 1.55% | 21.32% | 5.00% | 18.09% | 90.02% | 171.24% | 89.49% | 9.11% | -32.33% | $1.94B |
Inotiv, Inc.NOTV | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -52.83% | $553.0M |
Labcorp Holdings Inc.LH | 14.3% | 0.71% | 1.50% | -2.15% | 3.15% | 25.24% | 8.67% | 32.93% | 13.11% | 48.19% | 36.05% | $25.76B |
Maravai LifeSciences Holdings, Inc.MRVI | 14.3% | -2.96% | -5.50% | 3.74% | -3.87% | 121.85% | 102.53% | 226.24% | 118.48% | -6.12% | -82.37% | $1.99B |
Quest Diagnostics IncorporatedDGX | 14.3% | 1.68% | -2.87% | -1.97% | -0.12% | 33.01% | 8.92% | 38.09% | 27.21% | 55.89% | 74.56% | $25.48B |
| Theme return | — | -0.32% | -0.59% | 3.49% | 1.64% | 37.62% | 38.93% | 86.10% | 50.37% | 44.47% | 4.82% | — |
| Average | 14.3% | -0.32% | -0.59% | 4.00% | 1.15% | 35.37% | 39.59% | 81.16% | 45.91% | 23.80% | -12.01% | $10.06B |
| Median | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 25.24% | 8.92% | 38.09% | 27.21% | 9.11% | -27.17% | $1.99B |
| Std Dev | 0.0% | 1.35% | 2.45% | 7.70% | 2.82% | 38.88% | 41.89% | 81.82% | 43.99% | 27.11% | 49.58% | $10.81B |
| Min | 14.3% | -2.96% | -5.50% | -2.15% | -3.87% | 0.00% | 0.00% | 0.00% | 0.00% | -6.12% | -82.37% | $361.4M |
| Max | 14.3% | 1.68% | 1.55% | 21.32% | 5.00% | 121.85% | 102.53% | 226.24% | 118.48% | 59.50% | 74.56% | $25.76B |
| % Positive Tickers | 28.57% | 42.86% | 42.86% | 42.86% | 71.43% | 71.43% | 71.43% | 71.43% | 57.14% | 28.57% |